Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification

por Toyos, Melissa M.
Publicado 2019

Topical Ocular Anti-TNFα Agent Licaminlimab in the Treatment of Acute Anterior Uveitis: A Randomized Phase II Pilot Study

por Pasquali, Theodore A., Toyos, Melissa M., Abrams, David B., Scales, David K., Seaman, John W., Weissgerber, Georges
Publicado 2022

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease

por Tauber, Joseph, Schechter, Barry A, Bacharach, Jason, Toyos, Melissa M, Smyth-Medina, Robert, Weiss, Sidney L, Luchs, Jodi I
Publicado 2018

Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial

por Nichols, Kelly K, Holland, Edward, Toyos, Melissa M, Peace, James H, Majmudar, Parag, Raychaudhuri, Aparna, Hamdani, Mohamed, Roy, Monica, Shojaei, Amir
Publicado 2018